ZYUS Life Sciences Corporation
ZYUS.V
TSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 461.30K | 1.32M | 256.10K | 610.80K | 1.89M |
| Total Receivables | 218.50K | 254.40K | 299.80K | 800.80K | 582.70K |
| Inventory | 398.70K | 437.90K | 1.45M | 1.50M | 1.63M |
| Prepaid Expenses | 242.10K | 322.50K | 571.50K | 341.90K | 510.30K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 1.32M | 2.34M | 2.58M | 3.25M | 4.61M |
|
|
|||||
| Total Current Assets | 1.32M | 2.34M | 2.58M | 3.25M | 4.61M |
| Net Property, Plant & Equipment | 7.26M | 7.76M | 8.84M | 9.21M | 9.86M |
| Long-term Investments | -- | -- | 4.35M | 4.29M | 4.34M |
| Goodwill | -- | -- | 4.35M | 4.29M | 4.34M |
| Total Other Intangibles | -- | 0.00 | 9.28M | 9.29M | 9.31M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 105.80K | 105.60K | 112.50K | 111.10K | 112.30K |
| Total Assets | 8.69M | 10.20M | 25.15M | 26.15M | 28.23M |
|
|
|||||
| Total Accounts Payable | 5.25M | 3.12M | 6.77M | 5.88M | 4.61M |
| Total Accrued Expenses | -- | 2.34M | -- | -- | -- |
| Short-term Debt | 58.40K | 56.30K | 316.10K | 255.00K | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.29M | 6.56M | 3.50M | 4.87M | 4.85M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 8.60M | 12.08M | 10.58M | 11.01M | 9.46M |
|
|
|||||
| Total Current Liabilities | 8.60M | 12.08M | 10.58M | 11.01M | 9.46M |
| Long-Term Debt | 3.79M | 257.80K | 316.80K | 501.20K | 550.20K |
| Short-term Debt | 58.40K | 56.30K | 316.10K | 255.00K | -- |
| Capital Leases | 1.49M | 1.57M | 1.75M | 1.79M | 1.88M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | 1.49M | 1.50M | 1.51M |
| Total Liabilities | 13.88M | 13.91M | 14.13M | 14.80M | 13.40M |
|
|
|||||
| Common Stock & APIC | 115.99M | 115.31M | 120.22M | 116.69M | 117.81M |
| Retained Earnings | -123.80M | -120.93M | -112.70M | -108.38M | -105.99M |
| Treasury Stock & Other | 2.62M | 1.90M | 3.50M | 3.04M | 3.01M |
| Total Common Equity | -5.20M | -3.71M | 11.02M | 11.35M | 14.82M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -5.20M | -3.71M | 11.02M | 11.35M | 14.82M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -5.20M | -3.71M | 11.02M | 11.35M | 14.82M |
|
|
|||||